Molecular Formula: C400H625N111O115S9
Molecular Weight: 9117.53 g/mol
Sequence: MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPAKSA
Molecular Structure:
IGF-1 LR3 (Long Arg3 Insulin-like Growth Factor-1) is a synthetic peptide analog of human IGF-1, modified to enhance stability in controlled experimental environments. This analog incorporates an arginine substitution at position 3 and an extended amino acid sequence to alter its interaction profile in receptor-binding studies. In laboratory settings, IGF-1 LR3 is utilized in research involving peptide–receptor interactions, ligand binding dynamics, and intracellular signaling pathway analysis under defined in vitro conditions. This material is supplied in lyophilized powder form and is intended strictly for in vitro research and analytical applications.
IGF-1 LR3 is utilized in controlled research environments to support investigation of:
Insulin-like growth factor receptor (IGF-1R) binding and signaling pathway analysis
Ligand–receptor interaction modeling and affinity characterization
Intracellular signaling cascade evaluation associated with peptide ligands
Structure-function analysis of modified IGF-1 analogs
Stability, degradation, and analytical profiling in assay-based systems
All research applications are conducted in non-human, non-clinical experimental settings.
Store lyophilized powder at -20°C.
Once reconstituted, store at 2-8°C and use promptly.
Maintain aseptic techniques during laboratory handling.
Purity: ≥99% (HPLC Certified)
Appearance: Lyophilized white powder
Solubility: Soluble in suitable laboratory agents